Category: Health Science
-
![Element Nutrition (ELMT.C) leapfrogs almost the entire plant-based sector with mondo Walgreens drug store deal]()
Element Nutrition (ELMT.C) leapfrogs almost the entire plant-based sector with mondo Walgreens drug store deal
If you like plant-based companies on the public markets; if you think veganism and vegetarianism and pescatarianism and whole-foodism and ‘health and wellness’ism are all a positive thing, as I do, and as it seems a lot of investors do, then you’ve no shortage of stock tickers that’ll claim to be leading the space. But…
-
![Element Nutrition (ELMT.C) leapfrogs almost the entire plant-based sector with mondo Walgreens drug store deal]()
Element Nutrition (ELMT.C) leapfrogs almost the entire plant-based sector with mondo Walgreens drug store deal
If you like plant-based companies on the public markets; if you think veganism and vegetarianism and pescatarianism and whole-foodism and ‘health and wellness’ism are all a positive thing, as I do, and as it seems a lot of investors do, then you’ve no shortage of stock tickers that’ll claim to be leading the space. But…
-
![Analysis :Bionano Genomics (BNGO.Q) life sciences]()
Analysis :Bionano Genomics (BNGO.Q) life sciences
Bionano Genomics operates as a life sciences instrumentation company in the genome analysis space that provides tools and services based on their Saphyr system to scientists and clinicians conducting genetic research and patient testing and provides diagnostic testing for those with autism spectrum disorder and other neurodevelopmental disabilities through Lineagen, their wholly owned subsidiary. I…
-
![Bionano Genomics (BNGO.Q) under the microscope, taking a look at a company you may have missed]()
Bionano Genomics (BNGO.Q) under the microscope, taking a look at a company you may have missed
Bionano Genomics (BNGO.Q) has been keeping busy lately, and the Company’s Q2 2021 Financial Results are a testament to their efforts. Bionano has been on my radar for quite some time, although I couldn’t really tell you why. After all, I don’t know the first thing about genomics, let alone science. In fact, I almost…
-
![Bionano Genomics (BNGO.Q) under the microscope, taking a look at a company you may have missed]()
Bionano Genomics (BNGO.Q) under the microscope, taking a look at a company you may have missed
Bionano Genomics (BNGO.Q) has been keeping busy lately, and the Company’s Q2 2021 Financial Results are a testament to their efforts. Bionano has been on my radar for quite some time, although I couldn’t really tell you why. After all, I don’t know the first thing about genomics, let alone science. In fact, I almost…
-
![To Invest or Not: Diagnos (ADK.V)]()
To Invest or Not: Diagnos (ADK.V)
In this episode, we talk about DIAGNOS (ADK.V), a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging, and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment. We discuss what they do,…
-
![Chris’ Corner: Diagnos Inc (ADK.V)]()
Chris’ Corner: Diagnos Inc (ADK.V)
Chris Parry speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an in-depth look at how their diabetic retinopathy screening services work and what it means for optometrists and patients. Tune in!
-
![Diagnos (ADK.V) Renews Contract with Optina Diagnostics]()
Diagnos (ADK.V) Renews Contract with Optina Diagnostics
Diagnos (ADK.V) today announced a contract renewal to provide its telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics for an additional three-year period. “This contract renewal is a testimony of the high quality of our telemedicine platform and the agility of DIAGNOS people to adapt its platform to enable the rich…
-
![First Glance with Jody Vance – Medexus Pharma (MDP.T)]()
First Glance with Jody Vance – Medexus Pharma (MDP.T)
Vancouver’s own Jody Vance speaks with Ken d’Entremont, Medexus Pharmaceuticals (MDP.V) CEO and director, to find out more about the company’s mandate of bringing established drugs approved in other countries to patients in Canada. Listen in! <div algn=”center:><iframe width=”803″ height=”452″ src=”https://www.youtube.com/embed/r4MwrGgePDo” title=”YouTube video player” frameborder=”0″ allow=”accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture” allowfullscreen></iframe></div>
-
![Today’s Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the North American Pharmaceuticals Ladder]()
Today’s Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the North American Pharmaceuticals Ladder
Cancer is a bitch. Even if you haven’t had to battle against cancer yourself, you likely know someone who has. Unfortunately for me, that person was my mom; however, before this turns into a sob story let me assure you that my mom is alive and well after kicking cancer’s ass. My mom was diagnosed…
